<DOC>
	<DOCNO>NCT00767351</DOCNO>
	<brief_summary>Metformin widely use treatment type 2 diabetes mellitus . Side-effects mainly gastrointestinal tract . Since metformin clear blood exclusively via kidney reduce renal function relative contraindication . We earlier demonstrated metformin safely use low GFR level 30 ml/min/1.73 . Below level risk lactacidosis , severe complication , increase . In present study plan analyse serum level metformin repeatedly patient moderate renal failure ( CKD = GFR 30-60 ml/min/1.73 ) . Blood sample take trough value morning , week 0 , 2 , 4 , 8 four week blood sample take two hour intake morning dose metformin . Renal function estimate creatinine cystatin C occasion . The intraindividual variation metformin calculate . The study rest new method measure metformin . The technique use Liquid Chromatography Tandem Mass Spectometry ( LCMSMS ) . Proteins removed serum add acetonitrile sample . After centrifugation dilute portion supernatant inject LCMSMS-system . The total runtime sample 6 minute . The study show variation serum level metformin measure patient high low thus give u good understand whether change serum level due biological variation increase retention cause progressive renal failure .</brief_summary>
	<brief_title>Variation Serum Levels Metformin Patients With Reduced Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Patients age 18 year type 2 diabetes mellitus . Reduced renal function measure estimate GFR ( 60 ml/min/1.73 ) . Treatment metformin go . Severely reduced GFR ( &lt; 30 ml ( min/1.73 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>